These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8811466)

  • 1. Polyclonal B-cell activation by Neisseria meningitidis capsular polysaccharides elicit antibodies protective against Trypanosoma cruzi infection in vitro.
    Oliveira TG; Milani SR; Travassos LR
    J Clin Lab Anal; 1996; 10(4):220-8. PubMed ID: 8811466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
    Almeida IC; Milani SR; Gorin PA; Travassos LR
    J Immunol; 1991 Apr; 146(7):2394-400. PubMed ID: 1706399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.
    Rubinstein LJ; Stein KE
    J Immunol; 1988 Dec; 141(12):4357-62. PubMed ID: 3143763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of the immune response to the group B polysaccharide of Neisseria meningitidis.
    Lifely MR; Esdaile J
    Immunology; 1991 Nov; 74(3):490-6. PubMed ID: 1722773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein.
    Melo Coutinho CM; Cavalcanti GH; Bonaldo MC; Mortensen RF; Araújo-Jorge TC
    Exp Parasitol; 1998 Oct; 90(2):143-53. PubMed ID: 9769244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface polysaccharide of Moraxella non-liquefaciens identical to Neisseria meningitidis group B capsular polysaccharide. A chemical and immunological investigation.
    Bøvre K; Bryn K; Closs O; Hagen N; Frøholm LO
    NIPH Ann; 1983 Jun; 6(1):65-73. PubMed ID: 6413906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide.
    McNeil LK; Murphy E; Zhao XJ; Guttmann S; Harris SL; Scott AA; Tan C; Mack M; DaSilva I; Alexander K; Mason K; Jiang HQ; Zhu D; Mininni TL; Zlotnick GW; Hoiseth SK; Jones TR; Pride MW; Jansen KU; Anderson AS
    Vaccine; 2009 May; 27(25-26):3417-21. PubMed ID: 19200847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis.
    Jennings HJ; Roy R; Michon F
    J Immunol; 1985 Apr; 134(4):2651-7. PubMed ID: 2579148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
    Hurpin CM; Carosella ED; Cazenave PA
    Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate.
    Coquillat D; Bruge J; Danve B; Latour M; Hurpin C; Schulz D; Durbec P; Rougon G
    Infect Immun; 2001 Nov; 69(11):7130-9. PubMed ID: 11598089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
    Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the ontogeny of the murine humoral response to Neisseria meningitidis B capsular polysaccharide reveals levels of complexity relevant to vaccine development.
    Colino J; Outschoorn I
    J Infect Dis; 2001 Dec; 184(12):1538-47. PubMed ID: 11740729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
    Prinz DM; Smithson SL; Westerink MA
    J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.